NASDAQ : ASLN

ASLAN Pharmaceuticals Limited

$0.6 USD

-$0.1 (-14.27%)

Volume
769.82K
Average Volume
102.49K
Market Capitalization
$777.12M
P/E Ratio
-0.06
Dividend Yield
0.00%
Price Target
Year High
$17.04
Year Low
$0.48
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.84
3333332"{? p/.m7yd f,0=

Annual earnings financials

ASLN financial data with annual/quarterly toggle

ASLN GAAP EPS - Annual & Quarterly

ASLN Sales Revenue - Annual & Quarterly

ASLN Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ASLN Estimated and Actual Revenue by Quarter
ASLN Estimated and Actual EPS by Quarter
ASLN Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-12-31 0 - - - - - -
2025-09-30 0 - - - - - -
2025-06-30 0 - - - - - -
2025-03-31 0 - - - - - -
2024-12-31 0 - - - - - -
2024-09-30 0 - - - - - -
ASLN Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-12-31 0 -23.52M -23.52M -23.52M - - -
2025-09-30 0 -22.4M -22.4M -22.4M - - -
2025-06-30 0 -21.66M -21.66M -21.66M - - -
2025-03-31 0 -20.54M -20.54M -20.54M - - -
2024-12-31 0 -373.41K -373.41K -373.41K - - -
2024-09-30 0 -769.92K -723.71K -746.82K - - -
ASLN Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-12-31 0 - - - 1 -5.04 -5.04 -5.04
2025-09-30 0 - - - 1 -4.8 -4.8 -4.8
2025-06-30 0 - - - 1 -4.64 -4.64 -4.64
2025-03-31 0 - - - 1 -4.4 -4.4 -4.4
2024-12-31 0 - - - 1 -0.08 -0.08 -0.08
2024-09-30 0 - - - 1 -0.16495 -0.15505 -0.16